NCT02992041View on ClinicalTrials.gov

Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Laparoscopic Colorectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

December 27, 2016

Primary Completion Date

April 30, 2018

Study Completion Date

April 26, 2018

Conditions
Post-Operative Pain
Interventions
DRUG

VVZ-149 Injections

IV infusion of 900 or 1100 mg of VVZ-149

DRUG

Placebo

IV infusion of 0 mg of VVZ-149

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Vivozon, Inc.

INDUSTRY

NCT02992041 - Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Laparoscopic Colorectomy | Biotech Hunter | Biotech Hunter